General Information of the Compound
Compound ID |
CP0942328
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-((N-(2-(Dimethylamino)ethyl)propionamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C31H35N7O2
|
||||||||||||||||||
Molecular Weight |
537.668
|
||||||||||||||||||
Canonical SMILES |
CCC(=O)N(CCN(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C31H35N7O2/c1-5-29(39)38(18-17-37(3)4)21-23-9-11-24(12-10-23)30(40)34-26-13-8-22(2)28(19-26)36-31-33-16-14-27(35-31)25-7-6-15-32-20-25/h6-16,19-20H,5,17-18,21H2,1-4H3,(H,34,40)(H,33,35,36)
Show/Hide
|
||||||||||||||||||
InChIKey |
UZUAIPQVEDCJFL-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00888, Mast/stem cell growth factor receptor Kit
Protein ID: PT01092, Platelet-derived growth factor receptor alpha
Protein ID: PT00844, Platelet-derived growth factor receptor beta
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Cell Viability or Cytotoxicity Assay
Cell Line ID | Cell Line Name | Cell Line Organism | |
CL000077 | Ba/F3 | Mus musculus (Mouse) | 1 |
1 |
GI50 > 10000 nM
|
TI
LI
LO
TS
|
---|